Jonathan C. Fox
Director · Edgewise Therapeutics, Inc.
IndividualBuying only
- 2025
- Oct 2, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jonathan C. Fox files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alan J. Russell - $10.25M in EWTX purchases and sales in the last 12 months
- Joanne M. Donovan - $4.62M in EWTX purchases and sales in the last 12 months
- Badreddin Edris - $3.40M in EWTX purchases and sales in the last 12 months
- Kevin Koch - $785K in EWTX purchases and sales in the last 12 months
- Behrad Derakhshan - $223K in EWTX purchases and sales in the last 12 months
- John R. Moore - $220K in EWTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jonathan C. Fox?
Jonathan C. Fox is a corporate insider, tracked as Director of Edgewise Therapeutics, Inc. (EWTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jonathan C. Fox submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jonathan C. Fox been buying or selling stock?
Recorded transactions: 1 open-market purchase ($199K) and 0 open-market sales across all tracked filings.
